BRIEF-Insulet Initiates Voluntary Medical Device Correction For Certain Omnipod® Pods In The U.S. And Affected International Markets

Insulet

Insulet

PODD

0.00

May 26 (Reuters) - Insulet Corp PODD.O:

  • INSULET INITIATES VOLUNTARY MEDICAL DEVICE CORRECTION FOR CERTAIN OMNIPOD® PODS IN THE U.S. AND AFFECTED INTERNATIONAL MARKETS

  • INSULET CORP - SOME PODS MAY HAVE CANNULA TEAR CAUSING INSULIN UNDER-DELIVERY

  • INSULET CORP - ABOUT 7 MILLION PODS INCLUDED IN CORRECTION, 8.5% OF 2025 GLOBAL PRODUCTION

  • INSULET CORP - 24 SERIOUS ADVERSE EVENTS REPORTED GLOBALLY; NO DEATHS REPORTED

Source text: ID:nBw72kyLBa

Further company coverage: PODD.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.